Healthtech startup Fibroheal Woundcare raised Rs 6.3 Cr Pre-series A funding

In its pre-Series A round, Fibroheal Woundcare, a startup that makes medical devices based on silk proteins, raised Rs 6.3 crore from both new and existing investors, including bankers, surgeons, and medical professionals.

Existing and some new investors have also committed an additional Rs 10 crore to the company.

The money raised will be utilized to increase its go-to-market strategy, hire more staff, and fund its medical devices product pipeline.

Fibroheal was founded in 2017 by Vivek Mishra and Bharat Tandon, and its products are used in over 500 hospitals in more than 19 states in India. Additionally, the business has expanded to sell its goods on a number of e-commerce sites.

A variety of acute, chronic, traumatic, post-operative, non-healing, and difficult-to-heal wounds, such as bed sores or infected C-section wounds, can be healed with the company’s product line, which includes foams, mesh, and powders, among other things.

In the past, Fibroheal has raised money from current promoters KITVEN, CCAMP, and Telama Investments.